Hint mode is switched on Switch off

XPH - SPDR® S&P® Pharmaceuticals ETF (USD) (US78464A7220)

The comparsion limit has been reached: only 5 tools has been added. To add a new one, please remove one of the existing tools.

Choose all Reset all
 
(%)
US78464A7220
XPH ISIN
Exchange Traded Funds (ETF)
Type of fund
SPDR State Street Global Advisors
Provider
67.86 USD
NAV per Share | 15/07/2026
16/06/2006
Inception Date
4 times per year
Dividend payments
CEOILS
CFI
XPH
Ticker
Formed
Status
Equity
Investment category
Healthcare
Sector
USA
Investor locations
S&P Pharmaceuticals Select Industry Index
Benchmark
0.35 %
Total Cost Ratio
468.24 mln USD
Fund NAV | 15/07/2026
468.24 mln USD
Share Class NAV | 15/07/2026
No
UCITS

Upgrade to Premium features

Cbonds consolidates global bond, stock, ETF and indices data into a single platform — so you can analyze faster, make informed investment decisions and outperform the market

Get access
Welcome to Cbonds

  • Full access to the largest bond database

    Bond parameters,
    prospectuses

  • Seamless
    Data export

    Analyze the data in the most efficient way

  • Bond pricing

    Current & historical quotes from 400+ stock exchanges & OTC market

  • Smart risk assessment

    Credit ratings, financial reports

Get access

Yield on 15/07/2026, NYSE Arca

  • YTD
    1.13 %
  • 1M
    -5.91 %
  • 3M
    -2.73 %
  • 6M
    7.29 %
  • 1Y
    38.48 %
  • 3Y
    42.34 %
  • 5Y
    18.07 %
  • 10Y
    47.64 %
At the price on the exchange, taking into account income payments

Latest data on
Add to compare
from
to
ADD-IN
Cbonds add-in API
bond data api

Quotes (XPH)

Explore the most comprehensive database

1 000 000

bonds

100 000

stocks

175 910

ETF & Funds

100 000

indices

Track your portfolio in the most efficient way

  • Bond Search
  • Watchlist
  • Excel ADD-IN
Get access
×

— Are you looking for the complete & verified bond data?

— We have everything you need:

full data on over 1 000 000 bonds, 100 000 stocks, 100 000 indices, 17 000 ETF and 150 000 Mutual Funds; powerful bond screener; over 350 pricing sources among stock exchanges & OTC market; ratings & financial reports; user-friendly interface; available anywhere via Website, Excel Add-in and Mobile app.

Register
×

Why

You will have detailed descriptive & pricing data for 1M bonds, 100K stocks, 100K indices, 17K ETF and 150K Mutual Funds
Get full access to the platform from any device & via Cbonds app
Enhance your portfolio management with Cbonds Excel Add-in
Build yield maps, make chart comparison within a click
Don't wait any longer — start using Cbonds today! Register

Price dynamics

Fund profile

The SPDR S&P Pharmaceuticals ETF seeks to replicate as closely as possible the price and yield performance of the S&P Pharmaceuticals Select Industry Index by investing in a portfolio comprised primarily of U.S. companies in the pharmaceutical industry

XPH profile

The SPDR® S&P® Pharmaceuticals ETF (USD) is a(n) Equity Exchange Traded Funds (ETF) seeks to invest in Healthcare sector located in USA. The SPDR State Street Global Advisors fund’s base currency is USD and the share class was registered 16.06.2006 with unique ISIN - US78464A7220. Main exchange is NYSE Arca and ticker symbol is XPH. The total expense ratio is 0.35%. The SPDR® S&P® Pharmaceuticals ETF (USD) pays dividends 4 time(s) per year.

Structure XPH on 14/07/2026

Download structure in Excel
Paper Value
CRINETICS PHARMACEUTICALS IN 3.74%
DEFINIUM THERAPEUTICS INC 3.04%
MBX BIOSCIENCES INC 2.8%
ATAIBECKLEY INC 2.3%
ENLIVEN THERAPEUTICS INC 2.15%
ALUMIS INC 2.09%
AMYLYX PHARMACEUTICALS INC 2.07%
TREVI THERAPEUTICS INC 2.05%
NUVATION BIO INC 1.98%
MAZE THERAPEUTICS INC 1.86%
LIGAND PHARMACEUTICALS 1.86%
EDGEWISE THERAPEUTICS INC 1.85%
VERADERMICS INC 1.82%
NEKTAR THERAPEUTICS 1.82%
LIQUIDIA CORP 1.8%
CORCEPT THERAPEUTICS INC 1.78%
HARROW INC 1.77%
ELANCO ANIMAL HEALTH INC 1.71%
EYEPOINT INC 1.71%
OCULAR THERAPEUTIX INC 1.7%
AMNEAL PHARMACEUTICALS INC 1.67%
WAVE LIFE SCIENCES LTD 1.66%
PACIRA BIOSCIENCES INC 1.64%
JOHNSON + JOHNSON 1.63%
INDIVIOR PHARMACEUTICALS INC 1.62%
JAZZ PHARMACEUTICALS PLC 1.59%
SUPERNUS PHARMACEUTICALS INC 1.59%
VIATRIS INC 1.59%
OMEROS CORP 1.58%
BRISTOL MYERS SQUIBB CO 1.57%
ROYALTY PHARMA PLC CL A 1.57%
MERCK + CO. INC. 1.56%
ELI LILLY + CO 1.56%
ORGANON + CO 1.55%
COLLEGIUM PHARMACEUTICAL INC 1.54%
ANI PHARMACEUTICALS INC 1.51%
HARMONY BIOSCIENCES HOLDINGS 1.51%
PRESTIGE CONSUMER HEALTHCARE 1.47%
AXSOME THERAPEUTICS INC 1.47%
XERIS BIOPHARMA HOLDINGS INC 1.46%
PFIZER INC 1.45%
INNOVIVA INC 1.45%
RAPPORT THERAPEUTICS INC 1.44%
TARSUS PHARMACEUTICALS INC 1.41%
BIOAGE LABS INC 1.4%
ZOETIS INC 1.4%
PERRIGO CO PLC 1.36%
ETON PHARMACEUTICALS INC 1.36%
PHIBRO ANIMAL HEALTH CORP A 1.36%
ARVINAS INC 1.25%
ALTO NEUROSCIENCE INC 1.24%
AMPHASTAR PHARMACEUTICALS IN 1.17%
ZEVRA THERAPEUTICS INC 1.13%
PHATHOM PHARMACEUTICALS INC 1.09%
CORMEDIX INC 1.07%
SEPTERNA INC 1.03%
THERAVANCE BIOPHARMA INC 0.96%
RELMADA THERAPEUTICS INC 0.95%
ACLARIS THERAPEUTICS INC 0.92%
LB PHARMACEUTICALS INC 0.79%
AQUESTIVE THERAPEUTICS INC 0.75%
FULCRUM THERAPEUTICS INC 0.68%
LEXICON PHARMACEUTICALS INC 0.56%
EVOLUS INC 0.48%
SSI US GOV MONEY MARKET CLASS 0.16%
CONTRA ESPERION THERAP 0.01%
US DOLLAR -0.06%
Show more Hide
Other - %

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Other ETF & Funds from this provider

Similar ETF & Funds

  • {{ item.etf.ttl }}
    {{ item.nav_usd }} mln
    NAV
    {{ item.expense_ratio }}
    Total Cost Ratio
Registration is required to get access.